Recent advances in organometallic chemistry : synthetic, mechanistic and medicinal perspective /
Recent Advances in Organometallic Chemistry: Synthetic, Mechanistic and Medicinal Perspective highlights recent advancements in the field of organometallic chemistry.Containing essential information for researchers and advanced-level students, especially those working in chemical synthesis, the book...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Amsterdam :
Elsevier,
2024.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- 5.3.2 Iron-catalyzed C-H activation
- 5.3.3 Rhodium-catalyzed C-H activation
- 5.4 Future prospective and scope
- 5.5 Summary
- References
- 6 Organotransition metal chemistry in asymmetric catalysis mediated by different transition metal N-heterocyclic carbene co...
- 6.1 Introduction
- 6.2 Fundamental principles
- 6.3 Common methods of preparation
- 6.4 Mechanism involved
- 6.5 Recent developments with examples
- 6.6 Applications in emerging fields
- 6.7 Future prospective and scope
- 6.8 Summary
- 6.9 Problems with solutions
- 6.10 Objective type questions
- References
- 7 Organophosphorus compounds: recent developments and future perspective
- 7.1 Introduction
- 7.2 Fundamental principles
- 7.2.1 Phosphorus-based ligands
- 7.2.2 Classification of phosphorus-based ligands
- 7.3 Common methods of preparation
- 7.3.1 Pincer ligands
- 7.3.2 Synthesis of pincer complexes
- 7.3.2.1 C-H bond activation
- 7.3.3 Oxidative addition to aryl halide bond
- 7.3.4 Trans-metallation
- 7.3.5 Trans-cyclometallation
- 7.4 Classification of pincer complexes
- 7.4.1 Transition metal chemistry of pincer ligands
- 7.4.1.1 PCP pincer complexes
- 7.4.1.2 PNP pincer complexes
- 7.4.2 Application of tridentate chelating pincer complexes in catalysis
- 7.4.2.1 Heck cross-coupling reactions
- 7.4.2.2 Asymmetric allylation of sulfonimines
- 7.4.2.3 Hydrophosphination reaction
- 7.4.3 Chiral tridentate chelating pincer complexes
- 7.4.4 Aminophosphines
- 7.4.4.1 Cyclodiphosphazanes
- 7.4.4.2 Cis/trans isomerization
- 7.4.4.3 Synthesis of cyclodiphosphazanes
- 7.4.4.4 Reactivity of cyclodiphosphazanes
- 7.4.4.5 Macrocyclic cyclodiphosphazane derivatives
- 7.4.5 Phosphacyclophanes
- 7.5 Summary
- 7.6 Problems with solutions
- 7.7 Objective-type questions
- References.
- 8 Synthesis of silicon and germanium organometallic compounds and their applications in catalysis
- 8.1 Introduction
- 8.2 Synthesizing of silicon and germanium organometallic compounds
- 8.2.1 Direct synthesis
- 8.2.2 Hydrosilylation
- 8.2.3 Silenes
- 8.2.4 Silicones, silyl ethers, silanols, siloxanes, and siloxides
- 8.2.5 Bonding through carbon
- 8.3 Catalysis
- 8.4 Future prospective and scope
- 8.5 Summary
- 8.6 Problems with solutions
- 8.7 Objective type questions
- References
- 9 Sensing application of organometallic compounds
- 9.1 Introduction
- 9.2 Fundamental principles
- 9.3 Common methods of preparation
- 9.4 Mechanism involved
- 9.4.1 Ligand substitution
- 9.4.2 Oxidative addition
- 9.4.3 Concerted track based
- 9.5 Recent developments with examples
- 9.6 Applications in emerging fields
- 9.6.1 Chemical sensor
- 9.6.2 Gas sensor
- 9.6.3 Optical sensor
- 9.6.4 Biochemical sensor
- 9.7 Future prospective and scope
- 9.8 Summary
- 9.9 Problems with solutions
- 9.10 Objective type questions
- References
- 10 Bioorganometallic chemistry: a new horizon on organometallic landscape
- 10.1 Introduction
- 10.2 Shift from platinum metal based therapeutics to other bio-compatible less toxic nonplatinum complexes
- 10.2.1 Anticancerous properties of iron complexes
- 10.2.2 Anticancer properties of copper complexes
- 10.2.3 Anticancer properties of ruthenium complexes
- 10.2.3.1 Substitution modulated anticancer activity of Half-sandwich ruthenium (II) complexes with heterocyclic ancillary l...
- 10.2.4 Anticancer properties of gold complexes
- 10.2.5 Anticancer properties of rhodium and iridium complexes
- 10.3 Organoselenium compounds as potent chemotherapeutic agents
- 10.3.1 Inorganic selenium compounds
- 10.3.2 Organic selenium compounds
- 10.3.3 Selenocysteine
- 10.3.4 Selol.
- 10.3.5 Seleninic acids
- 10.3.6 Selenophene-based derivatives
- 10.3.7 1,2-Benzisoselenazole-3[2H]-one derivatives
- 10.3.8 Analysis of anticancer property of selenium-bearing 4-anilinoquinazoline compounds
- 10.3.8.1 Anticancer agent
- 10.3.9 Evaluation of indole chalcone and diarylketone derivatives containing selenium as tubulin polymerization inhibitory ...
- 10.3.9.1 Effect of diarylketone selenium derivative(compound-36) on the advancement of cell apoptosis
- 10.3.10 Chemopreventive applications of isoselenocyanate compounds
- 10.4 Other biological activities of organoselenium compounds
- 10.4.1 GPx activity
- 10.4.1.1 Catalytic GPx-like activity of 2,7-dialkoxy-substituted naphthalene-1,8-peri diselenides
- 10.4.1.2 pH-sensitive organoselenium compounds as pH-responsive glutathione peroxidase mimics
- 10.4.1.2.1 Mechanistic study
- 10.4.1.3 Enhanced activity as glutathione peroxidase mimics when benzo[d]isoselenazol-3-ones are combined with sterically h...
- 10.4.2 Anti-Alzheimer activity
- 10.4.2.1 Selenyl-dihydrofurans as anti-Alzheimer agents
- 10.4.2.2 Selenodihydropyrimidinones as potential multi-targeted treatments for Alzheimer's disease
- 10.4.2.3 AChE inhibitory activity
- 10.4.3 Cytoprotection
- 10.4.3.1 Organoselenium antioxidant compounds with cytoprotective effects
- 10.4.3.2 Bromo substituted diselenide compounds potential to scavenge ROS
- 10.4.4 Insecticidal activity
- 10.4.4.1 Selenoethers and their insecticidal activities
- 10.4.4.2 2,2-Difluoro-1,3-benzoxathioles (selenoles)with insecticidal activities
- 10.4.4.3 Selenium-containing imidazolium ionic liquids with antibacterial activity
- 10.4.4.4 Cyclization of Z-selenoenynes by iron(III)-PhSeSePh results in selenophenes with antidepressant-like activity
- 10.5 Different plausible mechanisms of action for bioorganometallic complexes.